Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9164 vs Tiotropium in COPD
NCT00939211Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd-9164 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jun 2009; status: completed.
02
Drugs
azd-9164
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00939211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939211.